inhaled dual PI3Kγ,δ kinase inhibitor Ph. II (3 mg QD) for asthma; withdrawn from re-opt. of oral PI3Kγ inhibitor Journal of Medicinal Chemistry AstraZeneca, Gothenburg, SE